These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4096529)

  • 21. Inhibiting the C5-C5a receptor axis.
    Woodruff TM; Nandakumar KS; Tedesco F
    Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of C5a in the absence of C3: a new complement activation pathway.
    Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
    Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL; Hugli TE
    Anal Biochem; 1984 Jan; 136(1):75-88. PubMed ID: 6711816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The release of C5a in complement-activated serum does not require C6.
    Biesecker G; Wagner JL; Hugli TE
    J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement and dengue haemorrhagic fever/shock syndrome.
    Malasit P
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):316-20. PubMed ID: 3501613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of complement by 405-nm light in serum from porphyria cutanea tarda.
    Torinuki W; Miura T; Tagami H
    Arch Dermatol Res; 1985; 277(3):174-8. PubMed ID: 4015182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase radioimmunoassay of human complement fragment C5a.
    Chang S; Leo-Mensah A; Campbell J; Stastny M; Patrick RA
    Clin Chem; 1988 Jun; 34(6):1018-21. PubMed ID: 3378318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratum corneum activation of complement through the antibody-independent alternative pathway.
    Terui T; Kato T; Tagami H
    J Invest Dermatol; 1989 Apr; 92(4):593-7. PubMed ID: 2649596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
    Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
    Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.
    Chenoweth DE
    Contrib Nephrol; 1987; 59():51-71. PubMed ID: 3327650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.
    van Dam AP; Hack CE
    Immunology; 1987 Jun; 61(2):105-10. PubMed ID: 3596635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay.
    Jose PJ; Forrest MJ; Williams TJ
    J Exp Med; 1983 Dec; 158(6):2177-82. PubMed ID: 6644242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.
    Kikuchi Y; Kaplan AP
    J Allergy Clin Immunol; 2002 Jan; 109(1):114-8. PubMed ID: 11799375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the alternative complement pathway by Fonsecaea pedrosoi.
    Torinuki W; Okohchi K; Takematsu H; Tagami H
    J Invest Dermatol; 1984 Oct; 83(4):308-10. PubMed ID: 6481182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
    Klos A; Ihrig V; Messner M; Grabbe J; Bitter-Suermann D
    J Immunol Methods; 1988 Jul; 111(2):241-52. PubMed ID: 3260926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro.
    Huber-Lang M; Denk S; Fulda S; Erler E; Kalbitz M; Weckbach S; Schneider EM; Weiss M; Kanse SM; Perl M
    Mol Immunol; 2012 Feb; 50(1-2):60-5. PubMed ID: 22244896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
    Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
    J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.